Next Article in Journal
Comparison of Gamma-Oryzanol Nanoemulsions Fabricated by Different High Energy Techniques
Previous Article in Journal
Effects of Ultrasound-Assisted Soy Lecithin Addition on Rehydration Behavior and Physical Properties of Egg White Protein Powder
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 13
Issue 14
10.3390/foods13142253
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits

by
Yeonhee Pyo
1,†,
Ki Han Kwon
2,† and
Yeon Ja Jung
1,*
1
Department of Beauty Cosmetics, College of Biomedical and Health Science, Konkuk University, Chungju 27478, Republic of Korea
2
College of General Education, Kookmin University, Seoul 02707, Republic of Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Foods 2024, 13(14), 2253; https://doi.org/10.3390/foods13142253
Submission received: 2 June 2024 / Revised: 30 June 2024 / Accepted: 6 July 2024 / Published: 17 July 2024
(This article belongs to the Section Food Nutrition)
Browse Figures
Versions Notes

Abstract

:
The term “flavonoid” encompasses a group of plant compounds, predominantly flavonoids, present in fruits, vegetables, and other plant-based foods. These compounds deliver significant health benefits, including potent antioxidant properties that protect cells from free radicals, thereby mitigating aging and disease. We assessed study quality and bias using the Cochrane Risk of Bias tool and the Newcastle−Ottawa Scale. Inclusion criteria specified that the studies must examine a natural flavonoid from fruits, must involve animal or human trials, must be original studies, and must be English articles on the flavonoid’s health and cancer-prevention effects, excluding conference abstracts and single-case studies. We conducted a comprehensive search of major databases including PubMed, Web of Science, Embase, SCOPUS, and Google Scholar, reviewing six clinical trials with total sample sizes of over 50 to 1500 participants. The results indicate that consuming flavonoid-rich fruits can aid in cancer prevention by targeting angiogenic and cancer-protective pathways. We specifically selected tomatoes, mulberries, Amazon grapes, apples, and citrus fruits due to their well-documented high levels of flavonoids and the robust clinical evidence supporting their physiological effects. In particular, citrus fruits contain additional beneficial phytochemicals that complement the action of flavonoids, enhancing their overall health effects. The anti-cancer mechanisms of flavonoids are not well-defined in the scientific literature, suggesting a gap that this study aims to address. Our study provides novel contributions by demonstrating how flavonoid supplementation induces anti-cancer effects through angiogenesis, anti-inflammatory actions, antioxidant-induced apoptosis, and modulation of pathways like PI3K/Akt and MAPK. These effects were particularly notable in the prevention and progression of breast, colon, liver, and lung cancers, with statistical significance (p < 0.05). By elucidating specific mechanisms and pathways, this study contributes to the understanding of flavonoids’ role in cancer prevention and underscores the potential for developing natural anti-cancer therapeutics through the inclusion of flavonoid-rich fruits in the diet. Future research should focus on randomized controlled trials assessing long-term effects of flavonoid supplementation in diverse populations, exploring optimal dosages, and understanding interactions with conventional cancer therapies to provide comprehensive evidence for clinical applications.

1. Introduction

The term “flavonoid” refers to a group of plant compounds, primarily flavonoids. Flavonoids can be obtained from a variety of fruits, vegetables, and plant-based foods and have a number of health benefits, including antioxidant effects. Rutin is one of the specific flavonoids found in fruit [1,2]. Flavonoids, sometimes referred to as bioflavonoids, are compounds that are an important component of a healthy diet and offer overall benefits to human health due to their antioxidant, anti-inflammatory, cardiovascular-health-enhancing, immune-system-boosting, and cancer-preventing effects [3]. The effects of flavonoids are very powerful and protect cells from harmful compounds such as free radicals, thereby preventing aging and disease [4]. They also regulate the immunomodulatory system, making them effective for preventing infections and inflammation [5]. They strengthen blood vessels to improve circulation and help prevent cardiovascular disease, especially by preventing damage to blood-vessel walls and reducing inflammation [6]. In addition, studies have shown that they support brain health, even impacting dementia and neurological diseases [7]. Despite the broad spectrum of health benefits, the specific mechanisms through which flavonoids exert their anti-cancer effects remain poorly understood. This study aims to address this gap by investigating how flavonoid-rich fruits contribute to cancer prevention. We focus on specific fruits such as tomatoes, mulberries, Amazon grapes, apples, and citrus fruits, which are known for their high flavonoid content and have robust clinical evidence supporting their health benefits. Citrus fruits, in particular, contain additional beneficial phytochemicals that work synergistically with flavonoids to enhance their overall health effects. Understanding these combined effects is crucial for developing effective dietary strategies for cancer prevention. Our research demonstrates how flavonoid supplementation induces anti-cancer effects through various mechanisms, including regulation of angiogenesis, anti-inflammatory actions, antioxidant-induced apoptosis, and modulation of key pathways such as phosphoinositide-3 kinase/RAC-alpha serine/threonine-protein kinase (PI3K/Akt) and mitogen-activated protein kinase (MAPK). These effects are especially notable in the prevention and progression of breast, colon, liver, and lung cancers, with statistical significance (p < 0.05). We highlight the role of flavonoids in modulating cell-signaling pathways, including the inhibition of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway and the promotion of apoptosis and autophagy in cancer cells.
Flavonoids, especially those found in fruits, play an important role in the food matrix and are attracting interest for their biosynthetic capabilities and optical properties, including fluorescence stability [8]. These flavonoids are not formed in the body, but their physiological functions affect the human body, and the mechanism of these effects is explained by the physiological functions of natural plant flavonoids such as quercetin, myricetin, rutin, and flavonoids of fruits [9]. Flavonoids are mostly found in yellow fruits such as pears, apples, plums, etc. [10]. Dietary flavonoids, such as quercetin, have emerged as promising anticancer candidates and are in clinical trials. Consumption of flavonoid-rich fruits has shown promising effects against certain cancers, particularly breast, colon, liver, and lung cancer [11]. Flavonoids prevent cancer through modulation of PI3K/Akt and MAPK pathways in breast cancer and exert anti-inflammatory effects and participate in antioxidant-induced apoptosis, fighting colon cancer [12]. In liver cancer, they are associated with antiangiogenic and antiproliferative effects, and in lung cancer, its mechanism of action operates through inhibition of the NF-kB pathway [13]. Positive correlations have been found for prostate, colon, and breast cancer; additionally, the scavenging of reactive oxygen species (ROS) and the induction of circulating apoptosis and autophagy suggest a role as a cancer-cell antioxidant and a positive modulator of pro-inflammatory cytokine signaling pathways [14].
Flavonoids have been reported to combat cancer through a mechanism of angiogenesis regulation [15]. The therapeutic properties of flavonoids are mediated through the modulation of cell-signaling pathways found downstream of PI3K tyrosine kinase growth receptor. They also have an opposite effect on signaling downstream of protein kinase B (Akt), a protein mutant effector protein of protein kinase A [16,17]. Flavonoids are involved in the modulation of Akt/PI3K/mammalian target of rapamycin (mTOR) pathway that stimulates and regulate the growth and development of cancer cells. They block PI3K activity and block crosstalk between PKB and PI3K, among other key proteins, including Akt, phosphatase and tensin homolog (PTEN), extracellular-signal-regulated kinase (ERK), and several others [18,19]. This effect attenuates H2O2-induced oxidative damage and induction of apoptosis in Leydig cells by the PI3K/Akt signaling pathway [20,21,22]. In addition, the adenosine triphosphate (PI3K-ATP) binding domain interferes with the mechanical target of the rapamycin complex 2 (mTORC2) complex to prevent Akt phosphorylation and induce antioxidant activity [23]. In response, flavonoids regulate the expression of various molecules, including glycogen synthase kinase-3 (GSK-3), and are involved in the promotion of TNF-α-induced apoptosis of human lung cancer cells [24]. The anticancer role of flavonoids is based on their role in angiogenesis through the expression of vascular endothelial growth factor (VEGF) [25,26]. They inhibit the activity of signal transducer and activator of transcription 3 (STAT3) by inhibiting proto-oncogene tyrosine-protein kinase Src kinase phosphorylation, which inhibits the growth and metastasis of cancer cells. STAT signaling is a characteristic signaling pathway in cancer, indicating a potential anticancer role for flavonoids [27,28,29].
Figure 1 depicts STAT5, STAT3, and Janus kinase 2 (JAK2) signaling acting to prevent the growth and differentiation of cancer cells. This systematic review therefore investigates the effect of these pathways on cancer prevention in the context of flavonoids derived from a healthy plant-based diet. We focus on the current literature on the role of flavonoid-involved signaling pathways. The STAT5, STAT3, and JAK2 signaling pathways play an important role in inhibiting the growth and differentiation of cancer cells. STAT proteins are key components of intracellular signaling pathways and are involved in cell growth, survival, differentiation, and inflammatory responses. In particular, STAT3 and STAT5 are overexpressed or overactivated in several types of cancer and are known to promote cancer progression and malignancy. JAK2 is an enzyme that is responsible for activating STAT proteins, making it an important part of the JAK-STAT pathway. This pathway involves binding to cytokine receptors on the cell surface to activate JAK2, which in turn phosphorylates and activates STAT proteins. Activated STAT proteins affect the growth and survival of cells by traveling to the nucleus and promoting the transcription of certain genes.
By elucidating these specific mechanisms and pathways, this study contributes to a comprehensive understanding of flavonoids’ role in cancer prevention. The findings underscore the potential for developing natural anti-cancer therapeutics through the inclusion of flavonoid-rich fruits in the diet. Future research should focus on randomized controlled trials assessing the long-term effects of flavonoid supplementation, exploring optimal dosages, and understanding interactions with conventional cancer therapies to provide comprehensive evidence for clinical applications.

2. Methods

Although this review was a narrative literature review, we searched PubMed, Medline, Web of Science, Embase, SCOPUS, and Google Scholar according to PRISMA guidelines, and the search-term chain was: “flavonoid”, “flavonoid compound”, “flavonoid subclass”, “flavonoid-rich”, “fruit”, “citrus fruit”, “berry”, “cancer prevention”, “anticancer”, “chemoprevention”, “cancer risk”, “reduction”, “health benefit”, “health effect”, “disease prevention”, “wellness”, “antioxidant”, “antioxidant activity”, “reactive oxygen species”, “free radical scavenging”, “dietary intake”, “nutrition”, “food source”, “flavonoid and health”, “signal transducer and activator of transcription”, “STAT”, and “nutrient”. Figure 2 shows a flowchart of the process involved in finding and selecting the studies included in this literature review. In addition, the search for recent publications (published from 2020 to 2024) included specific keywords such as “epidemiology”, “population study”, “cohort study”, “case-control study”, “clinical study”, “human trial”, “clinical trial”, and “intervention study”.

2.1. Eligibility Criteria

Studies included in this review had to meet the eligibility criteria for inclusion. Literature-review-relevant clinical case studies, randomized controlled trials, experimental studies, longitudinal studies, epidemiologic studies, and bioactivity studies related to flavonoids were included, while review articles, case analyses, theses, letters, editorials, articles without full text, and clinically problematic articles were excluded.

2.2. Screening and Data Extraction

Inclusion criteria required that studies be original research articles, review articles, internet articles, letters to the editor, editorials, opinions, protocols, perspectives, commentaries, short communications, or position papers. There were no publication-date or language restrictions for articles, reports, briefs, and series. Articles that did not contain raw data in accessible full text, that were of inappropriate status, that pertained to inappropriate subject matter, or that were irrelevant to the main focus of the article were excluded.

2.3. Study Selection and Data Extraction

The data-extraction process involved two independent reviewers examining the titles and abstracts of all included studies, selecting the most relevant studies, and reviewing the full text to extract the required data. A standardized form was used for data extraction, and any discrepancies were resolved by a third reviewer. We assessed the quality and risk of bias of the included studies using the Cochrane Collaboration’s Risk of Bias tool and the Newcastle−Ottawa Scale (NOS). The criteria included study design, sample size, data collection methods, clarity of results reporting, and statistical analysis methods. The Cochrane Risk of Bias tool evaluated domains such as random sequence generation, allocation concealment, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases. Each domain was rated as “low risk”, “high risk”, or “uncertain risk”. This systematic assessment determined the overall risk of bias for each study included in our review. The NOS scale, which assesses selection, comparability, and outcomes, has a maximum score of 9 and reflects the methodology, quality, and potential risk of bias in the study design. The results are summarized in Table 1 to highlight the strengths and weaknesses of the studies. Inclusion criteria required that publications be studies on natural flavonoids from fruits; studies conducted in animals or humans; original experimental studies published in English; and studies examining the effects of flavonoids on human health, lung health, and cancer prevention. Excluded were conference abstracts, single-presentation studies, and abstracts presented at conferences or seminars. From the initial 125 identified references, 84 duplicates were removed, leaving 41 unique articles. After rigorous evaluation, five articles met the inclusion criteria and were selected for detailed analysis. However, caution is warranted due to the varying risk of bias observed across the included studies. Sensitivity analyses reaffirmed the consistency of results across most conditions despite inconsistencies stemming from study design and participant characteristics synthesized through meta-analysis.

3. Dietary Sources of Flavonoid

Flavonoids can be obtained through the consumption of tomatoes, mulberries, Amazon grapes, apples, and citrus fruits, as shown in Table 1 [30,31,32,33,34]. Flavonoid-rich fruits and vegetables have been shown to be positively protective against colon, prostate, and breast cancer and may have protective effects as chemopreventive agents. Flavonoids interact with proteins through dietary intake, raising the possibility of using synthetic analogs as anticancer therapeutics [35]. Tomatoes provide flavonoids and phytochemicals, which are biosynthetic compounds that may protect against various types of cancer [36]. Phenolic compounds, flavonoids and carotenoids, vitamins, and tomatins (glycoalkaloids) have been identified as phytochemicals that are particularly beneficial in the prevention of chronic degenerative diseases and are widely recognized for their cancer-fighting properties [37]. Specific flavonoids in tomatoes have antiproliferative activity, inducing different types of apoptosis [38]. In addition, tomatoes contain quercetin3-β-D-glucoside, which has antiproliferative properties and has been proven to be safe and stable, providing a potent antiproliferative effect on cancer cell lines [39,40]. Quercetin and flavonoids provide the most growth inhibition with the least cytotoxicity against colon (HT-29 and HCT 116), breast (MCF-7), hepatocellular (HepG2), and lung cancer (A549) cells [41]. The flavonoids and polyphenols in tomatoes have been shown to be related to several transcription factors and the conversion of phenylalanine to trans-cinnamic acid by phenylalanine ammonia lyase (PAL), which in turn catalyzes the conversion of cinnamic acid 4-hydroxylase (C4H) to p-coumaric acid. This process occurs due to the spatial accumulation of polyphenols in the fruit and the utilization of the amino acid phenylalanine in the shikimate pathway via the phenylpropanoid biosynthetic pathway [42,43].
Mulberry is a nutritious food that has long been used in folk medicine for its antioxidant properties [44]. In particular, the polyphenolic compounds isoquercitrin, chlorogenic acid, quercetin, astragalin, and kaempferol, along with flavonoids, may attenuate obesity-related inflammation and attenuate type 2 diabetes [45]. Mulberry also has anti-cancer properties against breast, liver, colon, and lung cancer cells and is involved in apoptosis as a factor of PI3K, tumor protein p53, c-Jun N-terminal kinase, and nuclear factor-kappaB (NF-kB) [46,47]. Additionally, mulberry flavonoids have proven positive therapeutic effects against numerous diseases, including antioxidant, antidiabetic, antihyperlipidemic, and anti-obesity effects [48]. Chlorogenic acid from the leaves has been shown to help prevent steatohepatitis through a reduction in oxidative stress [49]. It also scavenges excess oxygen radicals produced by HepG2 cells in response to oxidative stress; prolongs the lifespan of HepG2 cells by regulating the nuclear factor erythroid 2-related factor 2 (Nrf-2) signaling pathway; and reduces inflammation by decreasing the expression of TNF-α, interleukin 6 (IL-6), inducible nitric oxide synthase (iNOS), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [50].
Phenolic compounds in Amazon grape have potentiating effects on several sulfur oxidizing enzymes, including glutathione and superoxide dismutase (SOD), and are associated with the expression and activation of catalase and other detoxification and antioxidant enzymes [51,52,53]. They are involved in triggering the apoptotic process in chronic degenerative diseases such as diabetes, cardiovascular disease, and various cancers due to their effects [54,55]. Amazon grape is also an excellent source of polyphenols, which have very powerful disease-preventing properties and have been shown to improve human health. It has health benefits against DNA damage, protein damage, unstable iron activity, and enzyme inhibition and has also been shown to inhibit the in vitro activities of AChE, tyrosinase, and α-amylase, suggesting its potential as a preventive treatment for disease [56]. The cancer chemopreventive effects of these grapes are attributed to flavonoids, as well as to raspberatrol, quercetin, kaempferol, catechins, epicatechins, and anthocyanins (cyanidins and malvidin), which underlie their chemopreventive and antiproliferative effects [57].
Along with flavonoids, apples are a major source of bioactive compounds such as phenols, flavonoids, terpenoids, and carotenoids, which play a role in reducing cancer risk [58,59]. These fruits are rich in flavonoids, each of which has a variety of anti-cancer and health-promoting properties. In particular, the flavonoids they contain have been clinically proven to have antioxidant, anti-inflammatory, and anti-cancer bioactive effects. Polyphenols in apples, including chlorogenic acid, epicatechin, caffeic acid, coumaric acid, quercetin-3-glucoside (Q3G), quercetin, phlorizin, and phloretin, are particularly effective in preventing cardiovascular disease, diabetes, and cancer through phytochemical action [60]. In addition to quercetin, flavonoids in apples exhibit strong antioxidant activity due to the presence of polyphenols, flavonoids, and various phytochemicals [61]. The amount of active ingredients is determined immediately after harvest due to potential losses during warehousing and storage changes [62].
Flavonoids and nobiletin, which are central to flavonoid changes and antioxidant solubility, decrease with fruit growth and development, as do a number of biologically active compounds in citrus fruits [63]. Polyphenols are found in various parts of citrus fruits, including the skin, peels, seeds, pulp membrane, and juice, and their flavonoids have been shown to have antiviral, antifungal, and antibacterial activity [64]. Flavonoids are present especially in many orange varieties and are present at especially high levels in grapefruit. Additionally, fruits such as sweet oranges, mandarin oranges, and lemons contain relatively small amounts of flavonoids, which are used as a dietary antioxidant, especially in Asian countries, where they are extracted in conjunction with the hesperidin component of oranges, mandarins, and grapefruit [64,65]. Additionally, the useful flavonoid glycosides in citrus fruits are known as flavonoids, and these combine with hydrogen peroxide to inhibit radical activity and protect against cellular damage. They play an important role in anti-cancer activity and are especially effective in protecting capillaries, reducing hemophilia symptoms, and relieving leg edema [66,67]. Citrus flavonoids also have cytotoxicity-reducing effects, reducing the risk of heart disease from oxidized low-density lipoprotein (LDL) and cholesterol and protecting cell walls [68]. Flavonoids from citrus fruits such as pomelo, lime, lemon, mandarin, and grapefruit are widely distributed in aromatic plants and are found in particularly high concentrations in their peels [69]. These citrus-peel flavonoid compounds are useful in cancer treatment, with strong preclinical anti-cancer mechanisms identified, including radical scavenging [70]. Sweet cherries are also an antioxidant-active fruit that contain flavonoids with anti-cancer properties and can be an effective supplement for prevention of cardiovascular disease, obesity, diabetes, and degenerative diseases. This is due to a variety of bioactive components, including flavonoids, which are natural antioxidants that are stable and bioavailable [71]. Hackberry is a fruit native to the Mediterranean region and has high antioxidant capacity based on phenols and flavonoids. It has antibacterial properties due to the flavonoids, and the flavonoid content varies depending on the climate and on the origin. Its anti-bacterial properties have a high correlation with chlorogenic acid levels [72]. However, the biological therapeutic potential of some of the flavonoids in fruits is determined by their type, bioavailability, and possible mode of action, so their pharmacological utilization in clinical trials and epidemiological studies is important [73].
Table 1. Fruits that serve as dietary sources of flavonoids.
Table 1. Fruits that serve as dietary sources of flavonoids.
Dietary SourceVitamin P ContentAnticancer PropertiesReference
TomatoAverage content of 20 mg 100 g−1
14–20 mg 100 g−1 on a dry basis		Flavonoids, lycopene and carotenoids protect against cellular damage and prevent prostate cancer and cardiovascular disease[30]
Mulberry fruitAverage content is 0.14 ± 0.050% DWStrengthens capillaries, reduces high blood pressure and decreases vascular permeability, has an anti-edema effect, reduces the risk of atherosclerosis, has antioxidant activity[31]
Amazon grapeThe rutin content in the peel is 155.45 ± 2.06 mg kg−1
Flesh 2.64 ± 1.21 mg kg−1 fresh weight		Cytotoxic effects in cancer cell lines[32]
Apple12.136~483.89 µg/gAntioxidant activity and activity similar to that of ascorbic acid[33]
Citrus fruits326.59 mg/100 gHealth-promoting effects of citrus-fruit extracts (grapefruit extract, pomelo extract, naringin, etc.) and flavonoid biological systems[34]
Sweet cherry1092.56 μg/g (MAE)
646.03 μg/g (CSE)		Various bioactive compounds, rutin, quercetin, quinic acid, and kaemferol-3-rutinoside
Suppresses cardiovascular disease, diabetes, degenerative diseases, and cancer		[71]
Hackberry0.55 µg/gPossesses phenolic compounds in addition to flavonoids, which have antibacterial and antifungal properties[72]
MAE, microwave-assisted extraction; CSE, conventional solvent extraction.

4. Flavonoid and Apoptosis Promotion

4.1. Chemical Structure of Flavonoids

Flavonoids are low-molecular-weight polyphenolic compounds found in more than 70 foods like grapefruit, cherries, apricots, buckwheat seeds, grapes, plums, and oranges. These compounds, known as citrus flavonoids, exhibit antioxidant, antibacterial, antiviral, and anti-inflammatory activities due to their hydroxyl groups [74]. They are also known as rutosides and sophorins and exhibit therapeutic activities such as antioxidant, antibacterial, antiviral, and anti-inflammatory activity due to the presence of hydroxyl groups [75,76]. The chemical structure of a flavonoid is shown in Figure 3.
Flavonoids act as plant-derived antioxidants with free-radical-scavenging properties, aiding in wound healing and supporting cell viability [77]. They are synthesized via the phenylpropanoid metabolic pathway, which involves converting phenylalanine to 4-coumaroyl-CoA and then to flavonoid structures through enzymatic modifications [78].

4.2. Anticancer Pathways of Flavonoids

Signaling pathways underlying molecular mechanisms of flavonoid activity are associated with strong activity of PI3K/Akt/GSK3β/NF-κB and p38/MK2 in colitis. Reduced expression of proinflammatory markers such as IgM, IgE, iNOS, ICAM-1, HO-1, and Th1/IL-10 cytokine ratios, as well as effects on effector modulation, regulation, and B cell homeostasis, represent a novel approach to treating colitis [79].
Flavonoids modulate several cell-signaling pathways, including PI3K/Akt, JAK/STAT, MAPK, and NF-κB, to exert anticancer effects [80]. They reduce inflammation and oxidative stress, inhibit platelet aggregation, and improve insulin sensitivity and lipid profiles, benefiting conditions like diabetes, hyperlipidemia, and cardiovascular disease [81,82]. Additionally, ROS-responsive nucleotide-binding domain-like receptor 3 (NLRP3) reverses endothelial dysfunction by enhancing and inhibiting nitric oxide production, which is in turn reduced by inflammasomes, thereby mitigating the risk of cardiovascular disease. Rutin has also been reported to counter neurodegenerative diseases by preventing neuroinflammation and abnormal protein accumulation and regulating cell death and microglial and astrocyte activation [83,84,85]. It has been reported to exert neuroprotective effects against various neurotoxins such as cisplatin, vancomycin, and mercury chloride through anti-inflammatory, antioxidant, anti-apoptotic, and aquaporin 1 level enhancement [86,87,88]. From another mechanistic perspective, rutin targets various inflammatory mediators such as NF-B-type κ and counteract TNF-α-induced inflammatory diseases. Hepatoprotective properties seen in animal models of nonalcoholic fatty-liver disease include abolishing key autophagy biomarkers and mitigating autophagy by regulating lipolysis and fat-synthesis genes [89]. In various preclinical models, flavonoids have also been shown to increase Nrf2 and to enhance the activities of enzymatic and non-enzymatic antioxidants such as SOD, CAT, and GPx, which may alleviate the aforementioned diseases [25,90].
Flavonoids may have a role in protection against dyslipidemia and breast cancer progression [91]. Elevated cholesterol levels are linked to uncontrolled cell growth and worse breast cancer prognosis [92]. Upregulation of FAS contributes to tumorigenesis by inhibiting apoptosis [93]. Specifically, flavonoids can inhibit cancer-cell growth by interfering with apoptosis and cell-cycle pathways. For example, they induce cell-cycle arrest in the G2/M phase and enhance apoptosis in breast cancer cells (MCF-7) by modulating the p53 and PTEN pathways [25,94,95]. They also counteract neurodegenerative diseases by preventing neuroinflammation and regulating cell-death mechanisms. Upregulation of p53 promotes activation of p21, leading to inhibition of numerous cell-cycle proteins, including CDK6, CDK2, CDK4, and cyclin B1 [96,97]. Flavonoids have been shown to modulate multiple signaling pathways involving Ras/Raf, PI3K/Akt, MAPK, TGF-β2/Smad2/3Akt/PTEN, either alone or in combination with other therapies. Additionally, flavonoids have been shown to enhance the effectiveness of chemotherapy drugs, reduce drug resistance, and mitigate chemotherapy-related side effects by synergistically inducing apoptosis in cancer cells [98].

5. Flavonoid-Rich Fruits

The flavonoids considered in this review include only natural flavonoids from fruits, which include compounds that are biosynthesized by a particular fruit (Table 2). The included methods involve quantitatively analyzing the amount of the compound in question in a sample of fruit. Clinically problematic articles include studies that have small sample sizes, use incorrect statistical analyses, or report results that have not been replicated in other studies. A Canadian case-control study showed that flavonoid intake had a favorable effect on lung cancer risk, and a Spanish case-control study showed that flavonoid intake may reduce the risk of colorectal cancer. The protective effect of flavonoid intake against breast cancer was particularly strong in Asian women and even stronger in postmenopausal women (OR 0.46, 95% CI 0.28–0.78). These findings show evidence from epidemiologic studies of flavonoid intake [99]. Dietary modification through fruit intake is essential for improving and positively impacting the prognosis of bladder cancer. A clinical trial involving 49 patients with non-muscle-invasive bladder cancer (NMIBC) demonstrated therapeutic benefits from a diet including Cruciferae [100]. The Mediterranean diet has been proven to reduce breast cancer recurrence [101]. Flavonoids naturally biosynthesized by tomatoes exhibit beneficial effects such as anti-oxidant activity. Additionally, the cleavage effect of flavonoids in tomatoes potentially leads to higher concentrations of secondary compounds such as polyphenols, lycopene, β-carotene, and lutein, which may enhance antioxidant capacity [102]. Dietary effects of tomatoes are also protective against prostate cancer [103]. Daily changes in fruit intake have demonstrated efficacy in preventing breast cancer [104], and clinical trials highlight the anti-atherosclerotic and anti-hyperglycemic effects of prickly pear (PP) fruit. PP juice consumption in healthy men positively affects heart-rate variability (HRV), total cholesterol (LDL-C, HDL-C), and glucose levels [105]. For cancer survivors, particularly older individuals, increased comorbidity and risk for secondary cancers necessitate diets rich in vegetables and fruits to improve overall health [106]. However, the clinical use of flavonoids must take into account their bioavailability, drug−drug interactions, and metabolic instability through isolation and purification from natural sources; mechanistic studies are also needed, as the flavonoids may be cytotoxic in their anticancer mechanisms [107].

6. Conclusions

The consumption of flavonoid-rich fruits is proposed as a potential lifestyle modification for cancer prevention, targeting angiogenic and cancer-protective pathways. However, it is important to note that while fruits rich in flavonoids also contain other phytochemicals that can benefit human health, the anti-cancer mechanisms of flavonoids remain underrepresented and poorly defined in the scientific literature. Our review highlights findings that supplementation with fruit products like citrus fruits (tomatoes, apples, grapes, and grapefruit) may induce angiogenic effects, anti-inflammatory actions, and antioxidant-induced apoptosis and may modulate pathways such as PI3K/Akt, MAPK, and TGF-β2/Smad2/3Akt/PTEN that are involved in anti-cancer responses. Future clinical trials focusing on flavonoids from fruits and vegetables, particularly on flavonoids from fruits, need to comprehensively address these mechanisms. Additionally, exploring the synergistic effects among various active ingredients and flavonoids in fruit foods, as well as examining multiple flavonoid compounds with anti-cancer potential, could serve as a foundation for developing natural anti-cancer therapeutics. However, it is essential to acknowledge the limitations and potential biases inherent in the reviewed studies to ensure a balanced and credible assessment of the findings.
To strengthen future research directions, it is crucial to focus on specific areas identified in this review. Firstly, conduct randomized controlled trials (RCTs) with larger, diverse populations to provide robust evidence on the efficacy of using flavonoid-rich fruits in cancer prevention. Secondly, prioritize mechanistic studies to elucidate how flavonoids inhibit angiogenesis and modulate pathways like PI3K/Akt and MAPK to exert anti-cancer effects. Thirdly, explore synergistic effects between flavonoids and other bioactive compounds in fruits for enhanced cancer prevention. Lastly, conduct longitudinal studies to assess the long-term dietary intake of flavonoids and its impact on cancer incidence and progression. Addressing these areas will advance our understanding and guide targeted clinical interventions in cancer prevention. Also, the conclusions would benefit from providing practical recommendations for clinicians and researchers. These recommendations should include specific guidance on incorporating flavonoid-rich fruits into dietary recommendations for cancer prevention. Additionally, suggesting targeted designs for clinical trials and mechanistic studies could fill existing research gaps effectively. These actionable insights can enhance studies’ relevance and impact in both clinical practice and further research endeavors.

Author Contributions

Conceptualization, Y.P. and K.H.K.; methodology, Y.P. and K.H.K.; soft-ware, Y.P. and K.H.K.; vali-dation, Y.P. and K.H.K.; formal analysis, Y.P. and K.H.K.; investigation, Y.P. and K.H.K.; resources, Y.P. and K.H.K.; data curation, Y.P. and K.H.K.; writing—original draft preparation, Y.P. and K.H.K.; writing—review, Y.P. and K.H.K.; editing, Y.P. and K.H.K.; visualization, Y.P. and K.H.K.; supervision, Y.J.J. All authors have read and agreed to the published version of the manuscript.

Funding

This paper was supported by Konkuk University in 2023.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The author declares no conflicts of interest.

Abbreviations

PI3K—phospholnositide-3 kinase; Akt—protein kinase B; ERK—extracellular signal-regulated kinase; PTEN—phosphatase and tensin homolog; PI3K-ATP—adenosine triphosphate; mTORC2—mechanistic target of rapamycin complex 2; GSK-3—synthase kinase-3; VEGF—vascular endothelial growth factor; STAT 3—signal transducers and activators of transcription 3; ROS—reactive oxygen species; PAL—phenylalanine ammonia lyase; C4H—cinnamic acid 4-hydroxylase; NF-kB—nuclear factor-kappaB; Nrf-2—nuclear factor erythroid 2-related factor 2; IL-6—interleukin 6; iNOS—inducible nitric oxide synthase; Q3G—quercetin-3-glucoside; LDL—low-density lipoprotein; PR—polylutein; NLRP3—nucleotide-binding domain-like receptor 3; NMIBC—non-muscle-invasive bladder cancer; PP—prickly pear; HRV—heart-rate variability; SRC—proto-oncogene tyrosine-protein kinase Src; mTOR—mammalian target of rapamycin.

References

  1. Wang, C.; Wang, X.; Zhang, Y.; Tang, Y.; Yang, Y.; Wang, B.; Wei, S.; Wang, Z.; Sun, G. Ionic liquid-based carbon dots as highly biocompatible and sensitive fluorescent probe for the determination of vitamin P in fruit samples. Food Chem. 2023, 406, 134898. [Google Scholar] [CrossRef]
  2. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An overview. J. Nutr. Sci. 2016, 5, e47. [Google Scholar] [CrossRef]
  3. Ullah, A.; Munir, S.; Badshah, S.L.; Khan, N.; Ghani, L.; Poulson, B.G.; Emwas, A.H.; Jaremko, M. Important Flavonoids and Their Role as a Therapeutic Agent. Molecules 2020, 25, 5243. [Google Scholar] [CrossRef]
  4. Michalak, M. Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process. Int. J. Mol. Sci. 2022, 23, 585. [Google Scholar] [CrossRef]
  5. Doaei, S.; Mardi, A.; Zare, M. Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review. Front. Nutr. 2023, 10, 1207237. [Google Scholar] [CrossRef]
  6. Mozos, I.; Flangea, C.; Vlad, D.C.; Gug, C.; Mozos, C.; Stoian, D.; Luca, C.T.; Horbańczuk, J.O.; Horbańczuk, O.K.; Atanasov, A.G. Effects of Anthocyanins on Vascular Health. Biomolecules 2021, 11, 811. [Google Scholar] [CrossRef]
  7. Rai, S.N.; Singh, P.; Steinbusch, H.W.M.; Vamanu, E.; Ashraf, G.; Singh, M.P. The Role of Vitamins in Neurodegenerative Disease: An Update. Biomedicines 2021, 9, 1284. [Google Scholar] [CrossRef]
  8. Choi, K.S.; Kundu, J.K.; Chun, K.S.; Na, H.K.; Surh, Y.J. Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in hairless mouse skin: p38 MAP kinase and JNK as potential targets. Arch. Biochem. Biophys. 2014, 559, 38–45. [Google Scholar] [CrossRef]
  9. Gutiérrez-Hoya, A.; Soto-Cruz, I. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins. Cells 2020, 9, 2297. [Google Scholar] [CrossRef]
  10. Qureshy, Z.; Johnson, D.E.; Grandis, J.R. Targeting the JAK/STAT pathway in solid tumors. J. Cancer Metastasis Treat. 2020, 6, 27. [Google Scholar] [CrossRef] [PubMed]
  11. Waheed Janabi, A.H.; Kamboh, A.A.; Saeed, M.; Xiaoyu, L.; BiBi, J.; Majeed, F.; Naveed, M.; Mughal, M.J.; Korejo, N.A.; Kamboh, R.; et al. Flavonoid-rich foods (FRF): A promising nutraceutical approach against lifespan-shortening diseases. Iran. J. Basic Med. Sci. 2020, 23, 140–153. [Google Scholar] [CrossRef]
  12. Rahmani, A.H.; Almatroudi, A.; Allemailem, K.S.; Alwanian, W.M.; Alharbi, B.F.; Alrumaihi, F.; Khan, A.A.; Almatroodi, S.A. Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways. Int. J. Mol. Sci. 2023, 24, 9665. [Google Scholar] [CrossRef]
  13. Krajka-Kuźniak, V.; Belka, M.; Papierska, K. Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones. Cancers 2024, 16, 1092. [Google Scholar] [CrossRef]
  14. Oh, H.; Park, S.H.; Kang, M.K.; Kim, Y.H.; Lee, E.J.; Kim, D.Y.; Kim, S.I.; Oh, S.; Lim, S.S.; Kang, Y.H. Asaronic Acid Attenuates Macrophage Activation toward M1 Phenotype through Inhibition of NF-κB Pathway and JAK-STAT Signaling in Glucose-Loaded Murine Macrophages. J. Agric. Food Chem. 2019, 67, 10069–10078. [Google Scholar] [CrossRef]
  15. Pandey, P.; Khan, F.; Qari, H.A.; Oves, M. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention. Pharmaceuticals 2021, 14, 1069. [Google Scholar] [CrossRef]
  16. Park, S.; Chapuis, N.; Tamburini, J.; Bardet, V.; Cornillet-Lefebvre, P.; Willems, L.; Green, A.; Mayeux, P.; Lacombe, C.; Bouscary, D. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica 2010, 95, 819–828. [Google Scholar] [CrossRef]
  17. Sharma, V.R.; Gupta, G.K.; Sharma, A.K.; Batra, N.; Sharma, D.K.; Joshi, A.; Sharma, A.K. PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation. Curr. Pharm. Des. 2017, 23, 1633–1638. [Google Scholar] [CrossRef]
  18. Fattahi, S.; Amjadi-Moheb, F.; Tabaripour, R.; Ashrafi, G.H.; Akhavan-Niaki, H. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci. 2020, 262, 118513. [Google Scholar] [CrossRef]
  19. Hosseinzade, A.; Sadeghi, O.; Naghdipour Biregani, A.; Soukhtehzari, S.; Brandt, G.S.; Esmaillzadeh, A. Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity. Front. Immunol. 2019, 10, 51. [Google Scholar] [CrossRef]
  20. Shakya, G.; Balasubramanian, S.; Hoda, M.; Rajagopalan, R. Inhibition of metastasis and angiogenesis in Hep-2 cells by wheatgrass extract—An in vitro and in silico approach. Toxicol. Mech. Methods 2018, 28, 205–218. [Google Scholar] [CrossRef]
  21. Banerjee, S.; Katiyar, P.; Kumar, V.; Waghmode, B.; Nathani, S.; Krishnan, V.; Sircar, D.; Roy, P. Wheatgrass inhibits the lipopolysaccharide-stimulated inflammatory effect in RAW 264.7 macrophages. Curr. Res. Toxicol. 2021, 2, 116–127. [Google Scholar] [CrossRef]
  22. Zhao, B.; Xiong, Y.; Zhang, Y.; Jia, L.; Zhang, W.; Xu, X. Rutin promotes osteogenic differentiation of periodontal ligament stem cells through the GPR30-mediated PI3K/AKT/mTOR signaling pathway. Exp. Biol. Med. 2020, 245, 552–561. [Google Scholar] [CrossRef]
  23. Sun, J.; Wang, H.; Liu, B.; Shi, W.; Shi, J.; Zhang, Z.; Xing, J. Rutin attenuates H2O2-induced oxidation damage and apoptosis in Leydig cells by activating PI3K/Akt signal pathways. Biomed. Pharmacother. 2017, 88, 500–506. [Google Scholar] [CrossRef]
  24. Talebi, H.; Farahpour, M.R.; Hamishehkar, H. The effectiveness of Rutin for prevention of surgical induced endometriosis development in a rat model. Sci. Rep. 2021, 11, 7180. [Google Scholar] [CrossRef]
  25. Nouri, Z.; Fakhri, S.; Nouri, K.; Wallace, C.E.; Farzaei, M.H.; Bishayee, A. Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach. Cancers 2020, 12, 2276. [Google Scholar] [CrossRef]
  26. Mohan, C.D.; Rangappa, S.; Preetham, H.D.; Chandra Nayaka, S.; Gupta, V.K.; Basappa, S.; Sethi, G.; Rangappa, K.S. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature. Semin. Cancer Biol. 2022, 80, 157–182. [Google Scholar] [CrossRef]
  27. Kim, M.; Baek, M.; Kim, D.J. Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis. Curr Pharm Des. 2017, 23, 4226–4246. [Google Scholar] [CrossRef]
  28. Chen, W.; Wang, S.; Wu, Y.; Shen, X.; Xu, S.; Guo, Z.; Xing, D. The physiologic activity and mechanism of quercetin-like natural plant flavonoids. Curr. Pharm. Biotechnol. 2020, 21, 654–658. [Google Scholar] [CrossRef]
  29. Morgacheva, N.V.; Zakharov, V.L.; Petrisheva, T.Y.; Sotnikova, E.B. Vitamin value assessment of fruits and berries in the Central Black Earth Region (CBER) by the level of biologically active substances in the wild analogues. IOP Conf. Ser. Earth Environ. Sci. 2020, 548, 072024. [Google Scholar] [CrossRef]
  30. Azad, A.K.; Dayoob, M.; Zohera, F.T. Anticancer Activity of Flavonoids: Past, Present, and Future. In Harnessing Medicinal Plants in Cancer Prevention and Treatmen; IGI Global: Hershey, PA, USA, 2024; pp. 1–21. [Google Scholar] [CrossRef]
  31. Tovar-Pérez, E.G.; Aguilera-Aguirre, S.; López-García, U.; Valdez-Morales, M.; Ibarra-Zurita, A.K.; Chacón-López, A. Effect of ultrasound treatment on the quality and contents of polyphenols, lycopene and rutin in tomato fruits. Czech J. Food Sci. 2020, 38, 20–27. [Google Scholar] [CrossRef]
  32. Wang, R.S.; Dong, P.H.; Shuai, X.X.; Chen, M.S. Evaluation of Different Black Mulberry Fruits (Morus nigra L.) Based on Phenolic Compounds and Antioxidant Activity. Foods 2022, 11, 1252. [Google Scholar] [CrossRef]
  33. Lopes-Lutz, D.; Dettmann, J.; Nimalaratne, C.; Schieber, A. Characterization and Quantification of Polyphenols in Amazon Grape (Pourouma cecropiifolia Martius). Molecules 2010, 15, 8543–8552. [Google Scholar] [CrossRef]
  34. Shafi, W.; Mansoor, S.; Jan, S.; Singh, D.B.; Kazi, M.; Raish, M.; Alwadei, M.; Mir, J.I.; Ahmad, P. Variability in Catechin and Rutin Contents and Their Antioxidant Potential in Diverse Apple Genotypes. Molecules 2019, 24, 943. [Google Scholar] [CrossRef]
  35. Batra, P.; Sharma, A.K. Anti-cancer potential of flavonoids: Recent trends and future perspectives. 3 Biotech 2013, 3, 439–459. [Google Scholar] [CrossRef]
  36. Patel, K.; Patel, D.K. The beneficial role of rutin, a naturally occurring flavonoid in health promotion and disease prevention: A systematic review and update. Bioact. Food Diet. Interv. Arthritis Relat. Inflamm. Dis. 2019, 457–479. [Google Scholar] [CrossRef]
  37. Chaudhary, P.; Sharma, A.; Singh, B.; Nagpal, A.K. Bioactivities of phytochemicals present in tomato. J. Food Sci. Technol. 2018, 55, 2833–2849. [Google Scholar] [CrossRef]
  38. Martí, R.; Roselló, S.; Cebolla-Cornejo, J. Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention. Cancers 2016, 8, 58. [Google Scholar] [CrossRef]
  39. Mazzucato, A.; Willems, D.; Bernini, R.; Picarella, M.E.; Santangelo, E.; Ruiu, F.; Tilesi, F.; Soressi, G.P. Novel phenotypes related to the breeding of purple-fruited tomatoes and effect of peel extracts on human cancer cell proliferation. Plant Physiol. Biochem. 2013, 72, 125–133. [Google Scholar] [CrossRef]
  40. de Araújo, M.E.; Moreira Franco, Y.E.; Alberto, T.G.; Sobreiro, M.A.; Conrado, M.A.; Priolli, D.G.; Frankland Sawaya, A.C.; Ruiz, A.L.; de Carvalho, J.E.; de Oliveira Carvalho, P. Enzymatic de-glycosylation of rutin improves its antioxidant and antiproliferative activities. Food Chem. 2013, 141, 266–273. [Google Scholar] [CrossRef]
  41. You, H.J.; Ahn, H.J.; Ji, G.E. Transformation of rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger. J. Agric. Food Chem. 2010, 58, 10886–10892. [Google Scholar] [CrossRef]
  42. Yang, J.; Liu, R.H. Synergistic effect of apple extracts and quercetin 3-beta-d-glucoside combination on antiproliferative activity in MCF-7 human breast cancer cells in vitro. J. Agric. Food Chem. 2009, 57, 8581–8586. [Google Scholar] [CrossRef]
  43. Khatri, P.; Chen, L.; Rajcan, I.; Dhaubhadel, S. Functional characterization of Cinnamate 4-hydroxylase gene family in soybean (Glycine max). PLoS ONE 2023, 18, e0285698. [Google Scholar] [CrossRef]
  44. Davies, K.M. Genetic modification of plant metabolism for human health benefits. Mutat. Res. 2007, 622, 122–137. [Google Scholar] [CrossRef]
  45. Ai, J.; Bao, B.; Battino, M.; Giampieri, F.; Chen, C.; You, L.; Cespedes-Acuña, C.L.; Ognyanov, M.; Tian, L.; Bai, W. Recent advances on bioactive polysaccharides from mulberry. Food Funct. 2021, 12, 5219–5235. [Google Scholar] [CrossRef]
  46. Peng, C.H.; Lin, H.T.; Chung, D.J.; Huang, C.N.; Wang, C.J. Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress. J. Food Drug Anal. 2018, 26, 778–787. [Google Scholar] [CrossRef]
  47. Demir, S.; Turan, I.; Aliyazicioglu, Y.; Kilinc, K.; Yaman, S.O.; Ayazoglu Demir, E.; Arslan, A.; Mentese, A.; Deger, O. Morus Rubra Extract Induces Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells Through Endoplasmic Reticulum Stress and Telomerase. Nutr. Cancer 2017, 69, 74–83. [Google Scholar] [CrossRef]
  48. Sarwar, M.S.; Zhang, H.J.; Tsang, S.W. Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways. Curr. Med. Chem. 2018, 25, 5057–5087. [Google Scholar] [CrossRef]
  49. Shang, A.; Luo, M.; Gan, R.-Y.; Xu, X.-Y.; Xia, Y.; Guo, H.; Liu, Y.; Li, H.-B. Effects of Microwave-Assisted Extraction Conditions on Antioxidant Capacity of Sweet Tea (Lithocarpus polystachyus Rehd.). Antioxidants 2020, 9, 678. [Google Scholar] [CrossRef]
  50. Wu, T.-Y.; Liang, J.; Ai, J.-Y.; Cui, J.-L.; Huang, W.-D.; You, Y.-L.; Zhan, J.-C. Mulberry Ethanol Extract and Rutin Protect Alcohol-Damaged GES-1 Cells by Inhibiting the MAPK Pathway. Molecules 2022, 27, 4266. [Google Scholar] [CrossRef]
  51. Wu, T.; Yin, J.; Zhang, G.; Long, H.; Zheng, X. Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet-induced obese mice. Mol. Nutr. Food Res. 2016, 60, 687–694. [Google Scholar] [CrossRef]
  52. Choi, S.K.; Zhang, X.H.; Seo, J.S. Suppression of oxidative stress by grape seed supplementation in rats. Nutr. Res. Pract. 2012, 6, 3–8. [Google Scholar] [CrossRef]
  53. Cetin, A.; Kaynar, L.; Koçyiğit, I.; Hacioğlu, S.K.; Saraymen, R.; Oztürk, A.; Orhan, O.; Sağdiç, O. The effect of grape seed extract on radiation-induced oxidative stress in the rat liver. Turk. J. Gastroenterol. 2008, 19, 92–98. [Google Scholar] [PubMed]
  54. Khan, S.G.; Katiyar, S.K.; Agarwal, R.; Mukhtar, H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in cancer chemoprevention. Cancer Res. 1992, 52, 4050–4052. [Google Scholar] [PubMed]
  55. Swartz, H.M.; Mason, R.P.; Hogg, N.; Kalyanaraman, B.; Sarna, T.; Plonka, P.M.; Zareb, M.; Gutierrez, P.L.; Berliner, L.J. Free Radicals and Medicine. Biomed. EPR Part A Free Radic. Met. Med. Physiol. 2005, 23, 25–74. [Google Scholar] [CrossRef]
  56. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239–247. [Google Scholar] [CrossRef]
  57. Habib, H.M.; El-Fakharany, E.M.; Kheadr, E.; Ibrahim, W.H. Grape seed proanthocyanidin extract inhibits DNA and protein damage and labile iron, enzyme, and cancer cell activities. Sci. Rep. 2022, 12, 12393. [Google Scholar] [CrossRef]
  58. Singh, C.K.; Siddiqui, I.A.; El-Abd, S.; Mukhtar, H.; Ahmad, N. Combination chemoprevention with grape antioxidants. Mol. Nutr. Food Res. 2016, 60, 1406–1415. [Google Scholar] [CrossRef]
  59. Alberti, A.; Zielinski, A.A.; Zardo, D.M.; Demiate, I.M.; Nogueira, A.; Mafra, L.I. Optimisation of the extraction of phenolic compounds from apples using response surface methodology. Food Chem. 2014, 149, 151–158. [Google Scholar] [CrossRef]
  60. Perussello, C.A.; Zhang, Z.; Marzocchella, A.; Tiwari, B.K. Valorization of Apple Pomace by Extraction of Valuable Compounds. Compr. Rev. Food Sci. Food Saf. 2017, 16, 776–796. [Google Scholar] [CrossRef]
  61. Nile, A.; Nile, S.H.; Shin, J.; Park, G.; Oh, J.-W. Quercetin-3-Glucoside Extracted from Apple Pomace Induces Cell Cycle Arrest and Apoptosis by Increasing Intracellular ROS Levels. Int. J. Mol. Sci. 2021, 22, 10749. [Google Scholar] [CrossRef]
  62. Pandey, J.; Bastola, T.; Tripathi, J.; Tripathi, M.; Rokaya, R.K.; Dhakal, B.; Poudel, A. Estimation of total quercetin and rutin content in Malus domestica of Nepalese origin by HPLC method and determination of their antioxidative activity. J. Food Qual. 2020, 2020, 8853426. [Google Scholar] [CrossRef]
  63. Zhu, C.; Zhou, X.; Long, C.; Du, Y.; Li, J.; Yue, J.; Pan, S. Variations of Flavonoid Composition and Antioxidant Properties among Different Cultivars, Fruit Tissues and Developmental Stages of Citrus Fruits. Chem. Biodivers. 2020, 17, e1900690. [Google Scholar] [CrossRef]
  64. Addi, M.; Elbouzidi, A.; Abid, M.; Tungmunnithum, D.; Elamrani, A.; Hano, C. An Overview of Bioactive Flavonoids from Citrus Fruits. Appl. Sci. 2022, 12, 29. [Google Scholar] [CrossRef]
  65. Bento-Silva, A.; Koistinen, V.M.; Mena, P.; Bronze, M.R.; Hanhineva, K.; Sahlstrøm, S.; Kitrytė, V.; Moco, S.; Aura, A.M. Factors affecting intake, metabolism and health benefits of phenolic acids: Do we understand individual variability? Eur. J. Nutr. 2020, 59, 1275–1293. [Google Scholar] [CrossRef] [PubMed]
  66. Yao, Q.; Lin, M.T.; Zhu, Y.D.; Xu, H.L.; Zhao, Y.Z. Recent Trends in Potential Therapeutic Applications of the Dietary Flavonoid Didymin. Molecules 2018, 23, 2547. [Google Scholar] [CrossRef]
  67. Moustafa, A.M.Y.; Ahmed, S.H.; Nabil, Z.I.; Hussein, A.A.; Omran, M.A. Extraction and phytochemical investigation of Calotropis procera: Effect of plant extracts on the activity of diverse muscles. Pharm. Biol. 2010, 10, 1080–1190. [Google Scholar] [CrossRef]
  68. Afraz, M.T.; Xu, X.; Adil, M.; Manzoor, M.F.; Zeng, X.-A.; Han, Z.; Aadil, R.M. Subcritical and Supercritical Fluids to Valorize Industrial Fruit and Vegetable Waste. Foods 2023, 12, 2417. [Google Scholar] [CrossRef]
  69. Koolaji, N.; Shammugasamy, B.; Schindeler, A.; Dong, Q.; Dehghani, F.; Valtchev, P. Citrus Peel Flavonoids as Potential Cancer Prevention Agents. Curr. Dev. Nutr. 2020, 4, nzaa025. [Google Scholar] [CrossRef]
  70. Benavente-García, O.; Castillo, J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185–6205. [Google Scholar] [CrossRef] [PubMed]
  71. Kashyap, P.; Riar, C.S.; Jindal, N. Effect of extraction methods and simulated in vitro gastrointestinal digestion on phenolic compound profile, bio-accessibility, and antioxidant activity of Meghalayan cherry (Prunus nepalensis) pomace extracts. LWT 2022, 153, 112570. [Google Scholar] [CrossRef]
  72. Farhan, M.; Rizvi, A.; Aatif, M.; Ahmad, A. Current Understanding of Flavonoids in Cancer Therapy and Prevention. Metabolites 2023, 13, 481. [Google Scholar] [CrossRef] [PubMed]
  73. Safari, F.; Hassanpour, H.; Alijanpour, A. Evaluation of hackberry (Celtis australis L.) fruits as sources of bioactive compounds. Sci. Rep. 2023, 13, 12233. [Google Scholar] [CrossRef] [PubMed]
  74. Orlikowski, L.B. Plant extracts in the control of Phytophthora cryptogea. Meded. Rijksuniv. Gent. Fak. Landbouwkd. Toegep. Biol. Wet. 2001, 66, 83–89. [Google Scholar] [PubMed]
  75. Goyal, J.; Verma, P.K. An overview of biosynthetic pathway and therapeutic potential of rutin. Mini Rev. Med. Chem. 2023, 23, 1451–1460. [Google Scholar] [CrossRef] [PubMed]
  76. Elancheziyan, M.; Ganesan, S.; Theyagarajan, K.; Duraisamy, M.; Thenmozhi, K.; Weng, C.H.; Ponnusamy, V.K. Novel biomass-derived porous-graphitic carbon coated iron oxide nanocomposite as an efficient electrocatalyst for the sensitive detection of rutin (vitamin P) in food and environmental samples. Environ. Res. 2022, 211, 113012. [Google Scholar] [CrossRef] [PubMed]
  77. Pivec, T.; Kargl, R.; Maver, U.; Bračič, M.; Elschner, T.; Žagar, E.; Gradišnik, L.; Stana Kleinschek, K. Chemical Structure–Antioxidant Activity Relationship of Water–Based Enzymatic Polymerized Rutin and Its Wound Healing Potential. Polymers 2019, 11, 1566. [Google Scholar] [CrossRef] [PubMed]
  78. Li, X.; Kim, J.K.; Park, S.Y.; Zhao, S.; Kim, Y.B.; Lee, S.; Park, S.U. Comparative analysis of flavonoids and polar metabolite profiling of Tanno-original and Tanno-high rutin buckwheat. J. Agric. Food Chem. 2014, 62, 2701–2708. [Google Scholar] [CrossRef] [PubMed]
  79. Li, C.; Tang, Y.; Ye, Y.; Zuo, M.; Lu, Q. Potential of natural flavonols and flavanones in the treatment of ulcerative colitis. Front. Pharmacol. 2023, 14, 1120616. [Google Scholar] [CrossRef]
  80. Imani, A.; Maleki, N.; Bohlouli, S.; Kouhsoltani, M.; Sharifi, S.; Maleki Dizaj, S. Molecular mechanisms of anticancer effect of rutin. Phytother. Res. 2021, 35, 2500–2513. [Google Scholar] [CrossRef]
  81. Sheu, J.R.; Hsiao, G.; Chou, P.H.; Shen, M.Y.; Chou, D.S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J. Agric. Food Chem. 2004, 52, 4414–4418. [Google Scholar] [CrossRef]
  82. Ghorbani, A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed. Pharmacother. 2017, 96, 305–312. [Google Scholar] [CrossRef]
  83. Wang, W.; Wu, Q.H.; Sui, Y.; Wang, Y.; Qiu, X. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome. Biomed. Pharmacother. 2017, 86, 32–40. [Google Scholar] [CrossRef] [PubMed]
  84. Ugusman, A.; Zakaria, Z.; Chua, K.H.; Nordin, N.A.; Abdullah Mahdy, Z. Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells. Sci. World J. 2014, 2014, 169370. [Google Scholar] [CrossRef] [PubMed]
  85. Wu, J.; Maoqiang, L.; Fan, H.; Zhenyu, B.; Qifang, H.; Xuepeng, W.; Liulong, Z. Rutin attenuates neuroinflammation in spinal cord injury rats. J. Surg. Res. 2016, 203, 331–337. [Google Scholar] [CrossRef] [PubMed]
  86. Enogieru, A.B.; Haylett, W.; Hiss, D.C.; Bardien, S.; Ekpo, O.E. Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. Oxid. Med. Cell Longev. 2018, 2018, 6241017. [Google Scholar] [CrossRef] [PubMed]
  87. Budzynska, B.; Faggio, C.; Kruk-Slomka, M.; Samec, D.; Nabavi, S.F.; Sureda, A.; Devi, K.P.; Nabavi, S.M. Rutin as Neuroprotective Agent: From Bench to Bedside. Curr. Med. Chem. 2019, 26, 5152–5164. [Google Scholar] [CrossRef] [PubMed]
  88. Radwan, R.R.; Abdel Fattah, S.M. Mechanisms involved in the possible nephroprotective effect of rutin and low dose γ irradiation against cisplatin-induced nephropathy in rats. J. Photochem. Photobiol. B 2017, 169, 56–62. [Google Scholar] [CrossRef] [PubMed]
  89. Qu, S.; Dai, C.; Lang, F.; Hu, L.; Tang, Q.; Wang, H.; Zhang, Y.; Hao, Z. Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats. Antimicrob. Agents Chemother. 2018, 63, e01545-18. [Google Scholar] [CrossRef] [PubMed]
  90. Liu, Q.; Pan, R.; Ding, L.; Zhang, F.; Hu, L.; Ding, B.; Zhu, L.; Xia, Y.; Dou, X. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Int. Immunopharmacol. 2017, 49, 132–141. [Google Scholar] [CrossRef]
  91. Munir, M.T.; Ponce, C.; Powell, C.A.; Tarafdar, K.; Yanagita, T.; Choudhury, M.; Gollahon, L.S.; Rahman, S.M. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. J. Steroid Biochem. Mol. Biol. 2018, 183, 1–9. [Google Scholar] [CrossRef]
  92. Garcia-Estevez, L.; Moreno-Bueno, G. Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res. 2019, 21, 35. [Google Scholar] [CrossRef] [PubMed]
  93. Xiao, F.; Wang, C.; Yin, H.; Yu, J.; Chen, S.; Fang, J.; Guo, F. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase. Oncotarget 2016, 7, 63679–63689. [Google Scholar] [CrossRef] [PubMed]
  94. Saleh, A.; ElFayoumi, H.M.; Youns, M.; Barakat, W. Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions. Naunyn Schmiedebergs Arch. Pharmacol. 2019, 392, 165–175. [Google Scholar] [CrossRef] [PubMed]
  95. Chen, J. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb. Perspect. Med. 2016, 6, a026104. [Google Scholar] [CrossRef] [PubMed]
  96. Xu, B.; Li, M.; Yu, Y.; He, J.; Hu, S.; Pan, M.; Lu, S.; Liao, K.; Pan, Z.; Zhou, Y.; et al. Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. Oncol. Lett. 2018, 15, 1931–1936. [Google Scholar] [CrossRef] [PubMed]
  97. Keay, S.; Nallar, S.C.; Gade, P.; Zhang, C.O.; Kalvakolanu, D.V. Oncosuppressor protein p53 and cyclin-dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expression. Cytokine 2018, 110, 110–115. [Google Scholar] [CrossRef]
  98. Zhou, Y.; Zheng, J.; Li, Y.; Xu, D.P.; Li, S.; Chen, Y.M.; Li, H.B. Natural Polyphenols for Prevention and Treatment of Cancer. Nutrients 2016, 8, 515. [Google Scholar] [CrossRef] [PubMed]
  99. Satari, A.; Ghasemi, S.; Habtemariam, S.; Asgharian, S.; Lorigooini, Z. Rutin: A flavonoid as an effective sensitizer for anticancer therapy; insights into multifaceted mechanisms and applicability for combination therapy. Evid.-Based Complement. Altern. Med. 2021, 9913179. [Google Scholar] [CrossRef]
  100. Yeary, K.H.K.; Yu, H.; Kuliszewski, M.G.; Li, Q.; McCann, S.E.; Pratt, R.; Saad-Harfouche, F.G.; Wang, Z.; Clark, N.; Wang, C.; et al. Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non-Muscle-Invasive Bladder Cancer. J. Natl. Compr. Cancer Netw. 2024, 22, e237086. [Google Scholar] [CrossRef] [PubMed]
  101. Berrino, F.; Villarini, A.; Gargano, G.; Krogh, V.; Grioni, S.; Bellegotti, M.; Venturelli, E.; Raimondi, M.; Traina, A.; Zarcone, M.; et al. The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial. Clin. Cancer Res. 2024, 30, 965–974. [Google Scholar] [CrossRef] [PubMed]
  102. Kapoor, L.; Simkin, A.J.; George Priya Doss, C.; Siva, R. Fruit ripening: Dynamics and integrated analysis of carotenoids and anthocyanins. BMC Plant Biol. 2022, 22, 27. [Google Scholar] [CrossRef]
  103. Paur, I.; Lilleby, W.; Bøhn, S.K.; Hulander, E.; Klein, W.; Vlatkovic, L.; Axcrona, K.; Bolstad, N.; Bjøro, T.; Laake, P.; et al. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clin. Nutr. 2017, 36, 672–679. [Google Scholar] [CrossRef] [PubMed]
  104. Burnell, M.; Gaba, F.; Sobocan, M.; Desai, R.; Sanderson, S.; Loggenberg, K.; Gessler, S.; Side, L.; Brady, A.F.; Dorkins, H.; et al. Randomised trial of population-based BRCA testing in Ashkenazi Jews: Long-term secondary lifestyle behavioural outcomes. BJOG 2022, 129, 1970–1980. [Google Scholar] [CrossRef] [PubMed]
  105. Gouws, C.A.; McKune, A.; Tee, N.; Somerset, S.; Mortazavi, R. Prickly pear juice consumption after fat intake affects postprandial heart rate variability but not traditional risk factors of cardiovascular disease in healthy men. Nutrition 2022, 96, 111555. [Google Scholar] [CrossRef] [PubMed]
  106. Kaur, H.; Fernández, J.R.; Locher, J.L.; Demark-Wahnefried, W. Rural and Urban Differences in Vegetable and Fruit Consumption Among Older Cancer Survivors in the Deep South: An Exploratory Cross-Sectional Study. J. Acad. Nutr. Diet 2022, 122, 1717–1724.e4. [Google Scholar] [CrossRef]
  107. Amawi, H.; Ashby, C.R., Jr.; Tiwari, A.K. Cancer chemoprevention through dietary flavonoids: What’s limiting? Chin. J. Cancer 2017, 36, 50. [Google Scholar] [CrossRef]
Foods 13 02253 g001
Figure 1. Mechanisms involved in the anticancer potential of flavonoids through the targeting of numerous molecular signaling pathways. Flavonoids inhibit cancer growth and differentiation by modulating key signaling pathways, including STAT5, STAT3, and JAK2. These pathways are crucial in cell growth, survival, and inflammatory responses. Overactivation of STAT3 and STAT5 is linked to cancer progression, while JAK2 activation is essential for STAT protein function in the JAK-STAT pathway.
Figure 1. Mechanisms involved in the anticancer potential of flavonoids through the targeting of numerous molecular signaling pathways. Flavonoids inhibit cancer growth and differentiation by modulating key signaling pathways, including STAT5, STAT3, and JAK2. These pathways are crucial in cell growth, survival, and inflammatory responses. Overactivation of STAT3 and STAT5 is linked to cancer progression, while JAK2 activation is essential for STAT protein function in the JAK-STAT pathway.
Foods 13 02253 g001
Foods 13 02253 g002
Figure 2. PRISMA flow diagram.
Figure 2. PRISMA flow diagram.
Foods 13 02253 g002
Foods 13 02253 g003
Figure 3. Chemical structure of a flavonoid.
Figure 3. Chemical structure of a flavonoid.
Foods 13 02253 g003
Table 2. Clinical trials of fruits rich in flavonoids.
Table 2. Clinical trials of fruits rich in flavonoids.
SubjectsTarget CancerSettingFindingsReference
49 NMIBC patientsBladder cancerTwo-arm, double-blinded, randomized controlled trial
A six-month intervention
Daily consumption of fruits and vegetables		Significantly increased cruciferae intake and urinary ITC levels in NMIBC Survivors
Improved bladder cancer outcomes and prognosis		[99]
1542 patients with breast cancerBreast cancerRandomized controlled trial
Randomly assigned to an active dietary intervention		5 years of follow-up; 95 patients in the IG and 98 in the CG developed breast cancer recurrence.
Self-reported diet at year 1 combined with IG and CG showed association of protection with higher degree of dietary change		[100]
79 patients with prostate cancerProstate cancerRandomized to a nutritional intervention
Controlled diet containing tomato products for 3 weeks.		A three-week nutritional intervention with tomato products alone or in combination with selenium and n-3 fatty acids lowers PSA in patients with metastatic prostate cancer.[102]
1034 participantsBreast cancerTwo-arm randomized controlled trialsSimilar long-term lifestyle influences include smoking, alcohol intake, dietary intake of fruit/vegetables/meat/vitamins, exercise, participation in breast cancer screening and reduced perception of cancer risk.[103]
17 male patientsCardiovascular diseaseDouble-blind, randomized, placebo-controlled, crossover trialMay moderate traditional responses to cardiovascular risk
Nutrient content is important		[104]
731 medicare-eligible cancer survivorsCancer preventionA cross-sectional secondary analysis
Kruskal−Wallis rank sum and post-hoc tests		Eating vegetables and fruits extends the life of cancer survivors.
Gender, race, and cancer type affect survival.		[105]
NMIBC, non-muscle-invasive bladder cancer: IG, intervention group: CG, control group: PSA, prostate cancer.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pyo, Y.; Kwon, K.H.; Jung, Y.J. Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits. Foods 2024, 13, 2253. https://doi.org/10.3390/foods13142253

AMA Style

Pyo Y, Kwon KH, Jung YJ. Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits. Foods. 2024; 13(14):2253. https://doi.org/10.3390/foods13142253

Chicago/Turabian Style

Pyo, Yeonhee, Ki Han Kwon, and Yeon Ja Jung. 2024. "Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits" Foods 13, no. 14: 2253. https://doi.org/10.3390/foods13142253

APA Style

Pyo, Y., Kwon, K. H., & Jung, Y. J. (2024). Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits. Foods, 13(14), 2253. https://doi.org/10.3390/foods13142253

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop